➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Harvard Business School
Dow
Mallinckrodt
Merck
Johnson and Johnson

Last Updated: January 27, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for L-Cysteine

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the drug development status for L-Cysteine?

L-Cysteine is an investigational drug.

There have been 18 clinical trials for L-Cysteine. The most recent clinical trial was a Phase 1 trial, which was initiated on June 15th 2020.

The most common disease conditions in clinical trials are Schizophrenia, Ovarian Neoplasms, and Hearing Loss, Noise-Induced. The leading clinical trial sponsors are Peking University People's Hospital, National Cancer Institute (NCI), and Cancer Research UK.

There are ninety-five US patents protecting this investigational drug and one international patent.

Recent Clinical Trials for L-Cysteine
TitleSponsorPhase
Effect of NAC on Preventing Chemo-Related Cognitive Impairments in Ovarian Ca Pts Treated W/ PBTJarrow Formulas IncPhase 1/Phase 2
Effect of NAC on Preventing Chemo-Related Cognitive Impairments in Ovarian Ca Pts Treated W/ PBTUniversity of California, IrvinePhase 1/Phase 2
Efficacy of N-Acetylcysteine (NAC) in Preventing COVID-19 From Progressing to Severe DiseaseCambridge Health AlliancePhase 4

See all L-Cysteine clinical trials

Clinical Trial Summary for L-Cysteine

Top disease conditions for L-Cysteine
Top clinical trial sponsors for L-Cysteine

See all L-Cysteine clinical trials

US Patents for L-Cysteine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
L-Cysteine   Start Trial Stable, highly pure L-cysteine compositions for injection and methods of use Exela Pharma Sciences, LLC (Lenoir, NC)   Start Trial
L-Cysteine   Start Trial Cysteine composition and injection Flamel Ireland Limited (Dublin, IE)   Start Trial
L-Cysteine   Start Trial Cysteine composition and injection Flamel Ireland Limited (Dublin, IE)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Harvard Business School
Dow
Mallinckrodt
Merck
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.